Gyre Therapeutics Files 8-K on Shareholder Vote
Ticker: GYRE · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1124105
| Field | Detail |
|---|---|
| Company | Gyre Therapeutics, Inc. (GYRE) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: GYRE
TL;DR
Gyre Therapeutics (GYRE) filed an 8-K for a shareholder vote on June 4th.
AI Summary
Gyre Therapeutics, Inc. filed an 8-K on June 6, 2025, reporting on a matter submitted to a vote of security holders on June 4, 2025. The company, formerly known as Catalyst Biosciences, Inc. and Targacept Inc., is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing indicates a significant corporate action or decision requiring shareholder approval, which could impact the company's future direction and stock performance.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not contain new financial or operational risks.
Key Players & Entities
- GYRE THERAPEUTICS, INC. (company) — Registrant
- CATALYST BIOSCIENCES, INC. (company) — Former company name
- TARGACEPT INC (company) — Former company name
- June 4, 2025 (date) — Date of earliest event reported
- June 6, 2025 (date) — Filing date
FAQ
What specific matter was submitted to a vote of Gyre Therapeutics' security holders?
The filing does not specify the exact matter submitted to a vote, only that it occurred on June 4, 2025.
When did Gyre Therapeutics file this 8-K report?
Gyre Therapeutics filed this 8-K report on June 6, 2025.
What is Gyre Therapeutics' principal executive office address?
The principal executive offices are located at 12770 High Bluff Drive, Suite 150, San Diego, CA 92130.
What were Gyre Therapeutics' former company names?
Gyre Therapeutics was formerly known as Catalyst Biosciences, Inc. and Targacept Inc.
In which state is Gyre Therapeutics incorporated?
Gyre Therapeutics is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding GYRE THERAPEUTICS, INC. (GYRE).